Tyr27
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr27  -  DVL2 (human)

Site Information
LDEEETPyLVkIPVP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 12170304

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 ) , mass spectrometry (in vitro) ( 3 ) , mutation of modification site ( 3 )
Disease tissue studied:
testicular cancer ( 3 )
Relevant cell line - cell type - tissue:
F9 (testicular) ( 3 ) , Jurkat (T lymphocyte) ( 1 , 2 )

Upstream Regulation
Kinases, in vitro:
Src (human) ( 3 )

Downstream Regulation
Effects of modification on biological processes:
transcription, induced ( 3 )

References 

1

Mulhern D (2011) CST Curation Set: 13031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

2

Zhou J (2011) CST Curation Set: 12026; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

3

Yokoyama N, Malbon CC (2009) Dishevelled-2 docks and activates Src in a Wnt-dependent manner. J Cell Sci 122, 4439-51
19920076   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.